Roots Global

Fund comparison

Explorer V versus First Pharma Fund

vs
Explorer Investments logo

Explorer V

Explorer Investments

Private EquityOpen
STAG Fund Management logo

First Pharma Fund

STAG Fund Management

Private EquityOpen

Residency permit & citizenship vs lock-up

Explorer V10-year lock-upFirst Pharma Fund8-year lock-up~Year 6: typical naturalization decision

Golden Visa applicants must keep the qualifying €500,000 invested while the residency is active; naturalization timelines vary by case. Not legal advice.

Key facts, side by side

4 of 12 differ · marks a difference
Explorer VFirst Pharma Fund
Minimum investment
€250k
€100k
Management fee p.a.
2%
Performance fee
20%
Hurdle rate
20%
Subscription fee
Redemption fee
Not disclosed
Lock-up
10 years
~8 years
Redemption
~At end of term
At end of term
Fund term
10 years
8 years
Target return
20–25%
~6.5%+
Fund size
€16M
Inception
Jan 2026

What the fees add up to

At least one of these funds has not published its management fee, so a like-for-like cost projection would be guesswork — we don't draw charts from missing data.

For US investors

  • Accepted

    Unconfirmed

  • PFIC

    PFIC status unclear

  • QEF statements

    Unconfirmed

  • IRA route

    Unconfirmed

  • Accepted

    Unconfirmed

  • PFIC

    PFIC expected, no QEF reporting confirmed

  • QEF statements

    Unconfirmed

  • IRA route

    Unconfirmed

Research coverage

63%

data completeness

0 fund documents linked · 4 sources cited

Full profile & sources →
58%

data completeness

0 fund documents linked · 5 sources cited

Full profile & sources →

This comparison restates researched data side by side — it is not a recommendation of either fund. Facts marked with a dash or "not disclosed" were not published; how much weight any difference deserves depends on your situation.